Ignite Creation Date:
2025-12-24 @ 2:56 PM
Ignite Modification Date:
2025-12-30 @ 8:05 PM
Study NCT ID:
NCT01031459
Status:
COMPLETED
Last Update Posted:
2012-01-05
First Post:
2009-12-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Telephone Interview of Patients That Participated in the the Pivotal Betaferon MS Trial.
Sponsor:
Bayer
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
14261
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Global Medical Affairs Therapeutic Area Head
Old Organization:
Bayer Healthcare Phamaceuticals Inc.